A 71-year-old male patient was admitted to our hospital to be operated for humeral metastasis of a left lung non-small-cell carcinoma including squamous cell carcinoma and adenocarcinoma parts. Routine pre-operative electrocardiography (ECG) revealed an abnormal pattern with marked ST-segment elevation in leads II-III-AVF (Fig. 1, Panel A) . However, the patient had not suffered from any symptoms such as chest pain or dyspnea. Chest radiography showed a left hilar mass (Fig. 1, Panel B) . First, cardiac enhanced computed tomography was performed. Coronary arteries had not been exposed to compression, and they exhibited no significant lesion that could lead to the above mentioned ECG Anatol
E-2 changes. However, an intramyocardial mass involving left ventricular basal inferior part, inferoseptal and inferolateral walls, was observed; moreover, the mass extended into the right ventricular lumen (Fig. 1 , Panel C) (Video 1). To clarify mass characterization, magnetic resonance imaging studies were performed. T2 series studies showed a mass with mildly increased signal intensity in the base of the heart (Fig. 1, Panel D) . Delayed-phase T2 series clearly revealed remarkable hemorrhagic necrosis in the central part of the tumor (Fig. 1 , Panel E) (Video 2). Thus, the course of diagnostic findings beginning with ST-segment elevation reached a diagnosis of cardiac metastasis of a lung cancer. We should keep in mind that ST-segment elevation might be related with cardiac metastasis in patients with cancer. To the best of our knowledge, this is a unique presentation considering the primary cancer type, cardiac metastasis localization, and STsegment elevation on ECG. 
